{"filing":{"accession_number":"0001575872-26-000531","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-07-23","report_date":null,"primary_document":"rdy0930_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000531/rdy0930_6k.htm"},"events":[{"id":19963,"run_id":17972,"accession_number":"0001575872-26-000531","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This exhibit discloses the results of shareholder votes at Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026. The members approved three resolutions: (1) re-appointment of Dr. K P Krishnan as an Independent Director for a second five-year term; (2) appointment of Mr. Srikanth Velamakanni as an Independent Director; and (3) appointment of Deloitte Haskins \u0026 Sells, LLP as Statutory Auditors. These are material governance matters affecting board composition and audit oversight, disclosed under Regulation 30 of the SEBI Listing Regulations.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-23","form":"6-K","submitted_at":null,"items":[{"id":19198,"accession_number":"0001575872-26-000531","item_number":"EX-99.1","item_title":"rdy0930_ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the results of shareholder votes at Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026. The members approved three resolutions: (1) re-appointment of Dr. K P Krishnan as an Independent Director for a second five-year term; (2) appointment of Mr. Srikanth Velamakanni as an Independent Director; and (3) appointment of Deloitte Haskins \u0026 Sells, LLP as Statutory Auditors. These are material governance matters affecting board composition and audit oversight, disclosed under Regulation 30 of the SEBI Listing Regulations.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-23T18:40:37.602510+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19198,"accession_number":"0001575872-26-000531","item_number":"EX-99.1","item_title":"rdy0930_ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the results of shareholder votes at Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026. The members approved three resolutions: (1) re-appointment of Dr. K P Krishnan as an Independent Director for a second five-year term; (2) appointment of Mr. Srikanth Velamakanni as an Independent Director; and (3) appointment of Deloitte Haskins \u0026 Sells, LLP as Statutory Auditors. These are material governance matters affecting board composition and audit oversight, disclosed under Regulation 30 of the SEBI Listing Regulations.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-23T18:40:37.602510+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-23"}]}